AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Innate Pharma S.A.

€1.55 -$0.07 (-4.44%)
PAR · 15 Sep 2026 15:35 UTC
Previous Close
€1.57
Day Range
€1.53€1.58
Year Range
€1.03€2.33
Market Cap
145.36M
AVG Volume
471.35K
Trailing/Forward PE
-2.81/-
PEG ratio
-0.08
Dividend Yield
-
Next Earnings Date
2026-09-17
Primary Exchange
Euronext ParisFR
Revenue (EUR)
-20M020M40M60M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Revenue (EUR) by quarter
PeriodRevenue (EUR)
25 Q4-2.07M
25 Q24.86M
24 Q47.78M
24 Q212.35M
23 Q421.44M
23 Q235.34M
22 Q48.31M
22 Q241.27M
21 Q42.79M
21 Q29.32M
Net Income (EUR)
-80M-60M-40M-20M020M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Net Income (EUR) by quarter
PeriodNet Income (EUR)
25 Q4-27.83M
25 Q2-21.34M
24 Q4-24.71M
24 Q2-24.76M
23 Q4-9.29M
23 Q21.72M
22 Q4-64.41M
22 Q26.3M
21 Q4-29.09M
21 Q2-23.72M
Operating Income (EUR)
-40M-30M-20M-10M010M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
25 Q4-31.93M
25 Q2-25.43M
24 Q4-25.26M
24 Q2-26.31M
23 Q4-12.27M
23 Q2-5.25M
22 Q4-28.8M
22 Q24.17M
21 Q4-30.9M
21 Q2-26.58M
EBITDA (EUR)
-40M-30M-20M-10M010M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
25 Q4-30.91M
25 Q2-25.06M
24 Q4-23.05M
24 Q2-25.56M
23 Q4-10.4M
23 Q2832K
22 Q4-10.08M
22 Q26.22M
21 Q4-26.91M
21 Q2-26.28M
Cash Flows (EUR)
-40M-30M-20M-10M010M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Cash Flows (EUR) by quarter
PeriodCash Flows (EUR)
25 Q4-21.67M
25 Q2-31.22M
24 Q4-10.04M
24 Q22.75M
23 Q4-21.14M
23 Q2-11.78M
22 Q4-20.91M
22 Q2628K
21 Q4-28.16M
21 Q2-31.57M
EPS (EUR)
-1-0.75-0.5-0.2500.2521 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA EPS (EUR) by quarter
PeriodEPS (EUR)
25 Q4-0.3
25 Q2-0.25
24 Q4-0.3
24 Q2-0.31
23 Q4-0.11
23 Q20.02
22 Q4-0.8
22 Q20.08
21 Q4-0.37
21 Q2-0.3
Expenses (EUR)
010M20M30M40MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Expenses (EUR) by quarter
PeriodExpenses (EUR)
25 Q432.13M
25 Q230.34M
24 Q432.3M
24 Q238.3M
23 Q432.31M
23 Q237.26M
22 Q435.43M
22 Q235.48M
21 Q432.31M
21 Q234.04M
Cash & Debt (EUR)
050M100M150MCashLong Term DebtShort Term Debt21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
25 Q434.31M
25 Q260.03M
24 Q480.77M
24 Q291.8M
23 Q492.46M
23 Q288.89M
22 Q4101.48M
22 Q2123.35M
21 Q4119.84M
21 Q2119.32M
Debt ratios
0123421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Debt ratios by quarter
PeriodDebt ratios
25 Q40.11
25 Q20.39
24 Q40.85
24 Q21.25
23 Q43.92
23 Q21.61
22 Q41.04
22 Q20.79
21 Q40.7
21 Q20.89
Margins
-1000%-750%-500%-250%0%250%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Margins by quarter
PeriodMargins
25 Q4-889.87%
25 Q2-322.22%
24 Q4-194.55%
24 Q2-135.53%
23 Q4-14.58%
23 Q255.5%
22 Q4-60.71%
22 Q269.77%
21 Q4-361.8%
21 Q2-13.79%
Return on Capital
-600%-400%-200%0%200%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Return on Capital by quarter
PeriodReturn on Capital
25 Q4128.24%
25 Q2-414.93%
24 Q4-279.68%
24 Q2-86%
23 Q4-17.9%
23 Q22.97%
22 Q4-118.94%
22 Q25.42%
21 Q4-27.08%
21 Q2-17.76%
Shares Outstanding
025M50M75M100M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Shares Outstanding by quarter
PeriodShares Outstanding
25 Q491.41M
25 Q285.38M
24 Q460.93M
24 Q260.93M
23 Q460.93M
23 Q260.93M
22 Q460.93M
22 Q260.93M
21 Q460.93M
21 Q260.93M
Book Value Per Share (EUR)
-1012321 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
25 Q4-0.24
25 Q20.06
24 Q40.14
24 Q20.47
23 Q40.85
23 Q20.95
22 Q40.89
22 Q21.91
21 Q41.76
21 Q22.19
Total Assets (EUR)
0100M200M300M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
IPH.PA Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
25 Q462.72M
25 Q292.94M
24 Q4111.06M
24 Q2151.5M
23 Q4184.19M
23 Q2199.05M
22 Q4207.86M
22 Q2280.43M
21 Q4267.5M
21 Q2266.22M
PE Ratio
95100105110115med 103.66Apr 17May 17Jun 17Jun 17Jul 17Aug 17Sep 17
IPH.PA PE Ratio by quarter
PeriodPE Ratio
Sep 1797.68
Sep 17103.66
Sep 17103.66
Sep 17103.56
Aug 17100.29
Aug 1798.24
Aug 1797.87
Aug 1799.64
Jul 17100.76
Jul 17101.98
Jul 17104.03
Jul 17100.39
Jun 17102.07
Jun 17114.12
Jun 17113.93
Jun 17111.5
Jun 17114.68
May 17112.9
May 17107.77
May 17107.86
May 17105.52
Apr 17105.9
Apr 1797.96
Apr 17102.63
Apr 17105.15
Mar 17108.98
Free Cash Flow Yield
-70%-60%-50%-40%-30%med -42.76%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IPH.PA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-41.94%
Sep 26-41.41%
Sep 26-37.62%
Aug 26-35.02%
Aug 26-34.47%
Aug 26-35.4%
Aug 26-43.6%
Jul 26-43.03%
Jul 26-41.41%
Jul 26-43.6%
Jul 26-41.94%
Jul 26-39.66%
Jun 26-41.67%
Jun 26-40.89%
Jun 26-42.21%
Jun 26-42.75%
May 26-40.89%
May 26-40.15%
May 26-37.84%
May 26-52.67%
Apr 26-54.87%
Apr 26-58.79%
Apr 26-47.71%
Apr 26-56.76%
Apr 26-56.76%
Mar 26-63.51%
Mar 26-65.29%
Mar 26-55.89%
Mar 26-50.26%
Feb 26-47.85%
Feb 26-49.55%
Feb 26-47.52%
Feb 26-48.85%
Jan 26-45.07%
Jan 26-45.66%
Jan 26-46.26%
Jan 26-45.96%
Jan 26-43.12%
Dec 25-45.07%
Dec 25-45.66%
Dec 25-42.86%
Dec 25-41.83%
Nov 25-39.92%
Nov 25-43.12%
Nov 25-43.94%
Nov 25-45.96%
Oct 25-41.83%
Oct 25-37.76%
Oct 25-37.97%
Oct 25-41.09%
Oct 25-38.38%
Sep 25-40.73%
Sep 25-41.76%
Sep 25-38.36%
Sep 25-37.28%
Aug 25-35.86%
Aug 25-32.83%
Aug 25-33.66%
Aug 25-36.05%
Aug 25-35.47%
Jul 25-36.86%
Jul 25-38.36%
Jul 25-43.99%
Jul 25-43.12%
Jun 25-42.3%
Jun 25-41.5%
Jun 25-39.04%
Jun 25-34.36%
May 25-33.49%
May 25-33.66%
May 25-34.36%
May 25-32.19%
May 25-33.49%
Apr 25-37.49%
Apr 25-37.7%
Apr 25-38.81%
Apr 25-38.36%
Mar 25-45.06%
Mar 25-44.58%
Mar 25-44.82%
Mar 25-41.29%
Feb 25-39.35%
Feb 25-38.1%
Feb 25-43.65%
Feb 25-42.76%
Jan 25-46.56%
Jan 25-49.01%
Jan 25-48.45%
Jan 25-46.31%
Jan 25-43.88%
Dec 24-42.98%
Dec 24-43.65%
Dec 24-44.11%
Dec 24-56.63%
Nov 24-59.02%
Nov 24-54.78%
Nov 24-58.2%
Nov 24-52.06%
Nov 24-49.3%
Oct 24-49.3%
Price to Sales
02468med 2Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IPH.PA Price to Sales by quarter
PeriodPrice to Sales
Sep 266.26
Sep 266.34
Sep 266.98
Aug 267.5
Aug 267.62
Aug 267.42
Aug 266.03
Jul 266.1
Jul 266.34
Jul 266.03
Jul 266.26
Jul 266.62
Jun 266.3
Jun 266.42
Jun 266.22
Jun 266.14
May 266.42
May 266.54
May 266.94
May 264.99
Apr 264.79
Apr 264.47
Apr 265.51
Apr 264.63
Apr 264.63
Mar 262.02
Mar 261.97
Mar 262.3
Mar 262.56
Feb 262.69
Feb 262.59
Feb 262.7
Feb 262.63
Jan 262.85
Jan 262.81
Jan 262.78
Jan 262.8
Jan 262.98
Dec 252.85
Dec 252.81
Dec 253
Dec 253.07
Nov 253.22
Nov 252.98
Nov 252.92
Nov 252.8
Oct 253.07
Oct 253.4
Oct 253.38
Oct 253.13
Oct 253.35
Sep 251.28
Sep 251.25
Sep 251.36
Sep 251.4
Aug 251.46
Aug 251.59
Aug 251.55
Aug 251.45
Aug 251.47
Jul 251.42
Jul 251.36
Jul 251.19
Jul 251.21
Jun 251.24
Jun 251.26
Jun 251.34
Jun 251.52
May 251.56
May 251.55
May 251.52
May 251.62
May 251.56
Apr 251.39
Apr 251.39
Apr 251.35
Apr 251.36
Mar 251.46
Mar 251.48
Mar 251.47
Mar 251.6
Feb 251.68
Feb 251.73
Feb 251.51
Feb 251.54
Jan 251.42
Jan 251.35
Jan 251.36
Jan 251.42
Jan 251.5
Dec 241.53
Dec 241.51
Dec 241.49
Dec 241.16
Nov 241.12
Nov 241.2
Nov 241.13
Nov 241.27
Nov 241.34
Oct 241.34
EV/EBITDA
050100150200med 66.66May 17Jul 17Oct 19Jan 20Oct 20Dec 20Mar 21
IPH.PA EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 2167.79
Mar 2167.08
Mar 2173.71
Mar 2166.25
Feb 2167.08
Feb 2167.98
Feb 2169.98
Feb 2169.33
Jan 2160.97
Jan 2165.99
Jan 2170.75
Jan 2172.42
Dec 2058.78
Dec 2060.91
Dec 2062.26
Dec 2059.62
Dec 2093.07
Nov 2096.35
Nov 2082.84
Nov 2077.25
Nov 2060.01
Oct 2056.86
Oct 2056.47
Oct 2055.18
Oct 2056.73
Oct 2050.68
Mar 2025.96
Mar 2017.64
Mar 2016.59
Mar 2044.72
Feb 2043.93
Feb 2052.07
Feb 2052.87
Feb 2048.2
Jan 2043.7
Jan 2047.35
Jan 2049.62
Jan 2043.01
Jan 2048.48
Dec 1938.74
Dec 1938.4
Dec 1933.44
Dec 1936.12
Nov 1935.61
Nov 1933.27
Nov 1934.58
Nov 1937.77
Nov 1932.93
Oct 1932.93
Oct 1935.61
Oct 1940.79
Oct 1950.88
Sep 17142.59
Sep 17155.65
Sep 17155.65
Sep 17155.44
Aug 17148.3
Aug 17143.81
Aug 17143
Aug 17146.87
Jul 17149.32
Jul 17151.97
Jul 17156.46
Jul 17148.51
Jun 17152.18
Jun 17178.5
Jun 17178.09
Jun 17172.79
Jun 17179.72
May 17175.85
May 17164.62
May 17164.83
May 17159.73
Apr 17160.54
Apr 17143.2
Apr 17153.4
Apr 17158.91
Mar 17167.28
Price/Operating Cashflow
050100150med 61.28Dec 16Apr 17Jul 17Nov 19Feb 20Jun 20Sep 20
IPH.PA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2058.02
Sep 2061.19
Sep 2061.38
Sep 2097.54
Aug 2099.9
Aug 2098.86
Aug 2097.83
Aug 2099.05
Jul 2097.64
Jul 20103.49
Jul 20104.44
Jul 20102.26
Jul 20104.72
Jun 20107.46
Jun 20108.21
Jun 20104.44
Jun 20106.32
May 20107.17
May 20105.57
May 20114.16
May 20130.31
Apr 20121.81
Apr 20116.14
Apr 20122.57
Apr 20108.59
Apr 20106.32
Mar 2097.27
Mar 2082.41
Mar 2080.54
Mar 20130.81
Feb 20129.38
Feb 20143.94
Feb 20145.36
Feb 20137.01
Jan 20128.97
Jan 20135.49
Jan 20139.56
Jan 20127.75
Jan 20137.52
Dec 19120.12
Dec 19119.51
Dec 19110.65
Dec 19115.43
Nov 19114.52
Nov 19110.34
Nov 19112.69
Nov 19118.39
Nov 19109.73
Oct 19109.73
Oct 19114.52
Oct 19123.78
Oct 19141.8
Sep 173.52
Sep 173.73
Sep 173.73
Sep 173.73
Aug 173.61
Aug 173.54
Aug 173.53
Aug 173.59
Jul 173.63
Jul 173.67
Jul 173.75
Jul 173.62
Jun 173.68
Jun 174.11
Jun 174.1
Jun 174.02
Jun 174.13
May 174.07
May 173.88
May 173.89
May 173.8
Apr 173.81
Apr 173.53
Apr 173.7
Apr 173.79
Mar 173.93
Mar 173.5
Mar 173.62
Mar 173.41
Mar 173.21
Feb 173.17
Feb 173.34
Feb 173.39
Feb 174.07
Jan 174.31
Jan 174.33
Jan 174.77
Jan 174.8
Dec 164.54
Dec 164.44
Dec 164.17
Dec 164.18
Dec 164.23
Nov 164.41
Nov 164.48
Nov 164.14
Nov 163.31
Oct 163.43
Price to Book
010203040med 10.66Jul 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
IPH.PA Price to Book by quarter
PeriodPrice to Book
Mar 2618.26
Mar 2617.76
Mar 2620.75
Mar 2623.07
Feb 2624.23
Feb 2623.4
Feb 2624.4
Feb 2623.73
Jan 2625.73
Jan 2625.39
Jan 2625.06
Jan 2625.23
Jan 2626.89
Dec 2525.73
Dec 2525.39
Dec 2527.05
Dec 2527.72
Nov 2529.05
Nov 2526.89
Nov 2526.39
Nov 2525.23
Oct 2527.72
Oct 2530.7
Oct 2530.54
Oct 2528.22
Oct 2530.21
Sep 2511.17
Sep 2510.9
Sep 2511.86
Sep 2512.21
Aug 2512.69
Aug 2513.86
Aug 2513.52
Aug 2512.62
Aug 2512.83
Jul 2512.35
Jul 2511.86
Jul 2510.35
Jul 2510.55
Jun 2510.76
Jun 2510.97
Jun 2511.66
Jun 2513.24
May 2513.59
May 2513.52
May 2513.24
May 2514.14
May 2513.59
Apr 2512.14
Apr 2512.07
Apr 2511.72
Apr 2511.86
Mar 253.94
Mar 253.98
Mar 253.96
Mar 254.3
Feb 254.51
Feb 254.65
Feb 254.06
Feb 254.15
Jan 253.81
Jan 253.62
Jan 253.66
Jan 253.83
Jan 254.04
Dec 244.13
Dec 244.06
Dec 244.02
Dec 243.13
Nov 243
Nov 243.24
Nov 243.05
Nov 243.41
Nov 243.6
Oct 243.6
Oct 243.96
Oct 244.06
Oct 244.15
Sep 242.36
Sep 242.31
Sep 242.44
Sep 242.48
Aug 242.45
Aug 242.45
Aug 242.42
Aug 242.32
Aug 242.38
Jul 242.49
Jul 242.41
Jul 242.42
Jul 242.35
Jun 242.2
Jun 242.42
Jun 242.5
Jun 242.98
May 242.97
May 243.13
May 242.83
May 242.65
May 242.59
Innate Pharma S.A.
IPH.PA
Stockpicker

Video analysis: IPH.PA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.